News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Aman Chauhan: Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!
Photo taken from Aman Chauhan/X
Sep 11, 2023, 18:28

Aman Chauhan: Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!

Quoting Aman Chauhan, Leader of the Sylvester Comprehensive Cancer Center’s Neuroendocrine Tumor Program, on Twitter: 

“Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!! We are now even more excited for Paltusotine Carcinoid study. Please checkout our Trials in Progress Poster from ENETS.”
For details click here.
Source: Aman Chauhan/Twitter
Aman Chauhan cancer Crinetics Pharmaceuticals OncoDaily Oncology paltusotine
Special Coverage
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public